Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 GBI Awarded Process Development Sub-Contract | Contract Pharma

What are you searching for?

Sign in
Breaking News

GBI Awarded Process Development Sub-Contract

Will conduct process development for Anthrax Vaccine

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Goodwin Biotechnology, Inc. (GBI) was awarded a sub-contract from Emergent BioSolutions to conduct an early stage proof-of-concept feasibility process development to concentrate AVA filtrate for storage before the downstream process for BioThrax (Anthrax Vaccine Adsorbed). BioThrax is the only vaccine licensed by the FDA for the protection against anthrax disease. 
 
“We’re excited about the opportunity to contribute our protein purification as well as processing experience and expertise which have been developed and refined over the last 20 years,” said Muctarr Sesay, Ph.D., vice president of process development at GBI. “Our goal is to develop process parameters that are amenable to routine GMP production and large-scale manufacturing in an effort to contribute to the production of BioThrax at large scale.”
 
Heidi Nielsen, process development engineer for the Biodefense Division of Emergent BioSolutions said, “This phase of process development is critical to our project. We chose to work with Goodwin Biotechnology based on their Quality Systems and experience with large scale, GMP-compliant protein purification and processing.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics